title: Complement receptor 3 promotes severe ross river virus-induced disease.
abstract: Alphaviruses such as Ross River virus (RRV) and chikungunya virus are mosquito-transmitted viruses that cause explosive epidemics of debilitating arthritis and myositis affecting millions of humans worldwide. Previous studies using a mouse model of RRV-induced disease demonstrated that viral infection results in a severe inflammatory arthritis and myositis and that complement component 3 (C3) contributes to the destructive phase of the inflammatory disease but not the recruitment of cellular infiltrates to the sites of RRV-induced inflammation. Here, we demonstrate that mice deficient in complement receptor 3 (CR3) (CD11b(-/-)), a signaling receptor activated by multiple ligands including the C3 cleavage fragment iC3b, develop less-severe disease signs and decreased tissue destruction compared to RRV-infected wild-type mice. CR3 deficiency had no effect on viral replication, nor did it diminish the magnitude, kinetics, and composition of the cellular infiltrates at the sites of inflammation. However, the genetic absence of CR3 diminished the expression of specific proinflammatory and cytotoxic effectors, including S100A9/S100A8 and interleukin-6, within the inflamed tissues, suggesting that CR3-dependent signaling at the sites of inflammation contributes to tissue damage and severe disease.
authors.affiliation: The Carolina Vaccine Institute, University of North Carolina at Chapel Hill, 9024 Burnett Womack, CB #7292, Manning Drive, Chapel Hill, NC 27599. heisem@med.unc.edu.
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Morrison
authors.forename: Jason D
authors.initials: JD
authors.lastname: Simmons
authors.forename: Mark T
authors.initials: MT
authors.lastname: Heise
mesh_terms: D018354:Alphavirus Infections / Q000276:immunology* / Q000473:pathology*; D000818:Animals; D040502:Calgranulin B / Q000096:biosynthesis; D015850:Interleukin-6 / Q000096:biosynthesis; D007596:Joints / Q000473:pathology / Q000821:virology; D016177:Macrophage-1 Antigen / Q000235:genetics / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D018482:Muscle, Skeletal / Q000473:pathology / Q000821:virology; D012398:Ross River virus / Q000276:immunology*; D012720:Severity of Illness Index; D019562:Viral Load
chemical_list: D040502:Calgranulin B; D015850:Interleukin-6; D016177:Macrophage-1 Antigen
references.citation: Lancet Infect Dis. 2008 Jan;8(1):2-3
references.pmid: 18156079
references.citation: Cardiovasc Res. 2003 Sep 1;59(3):723-33
references.pmid: 14499874
references.citation: J Cell Biol. 1990 Dec;111(6 Pt 2):3129-39
references.pmid: 1980124
references.citation: J Clin Invest. 1989 Jun;83(6):2008-17
references.pmid: 2566624
references.citation: Arthritis Res Ther. 2006;8(3):R69
references.pmid: 16613612
references.citation: J Immunol. 2006 Aug 1;177(3):1661-9
references.pmid: 16849475
references.citation: J Exp Med. 1987 Mar 1;165(3):733-49
references.pmid: 3102677
references.citation: Med J Aust. 2002 Oct 7;177(7):352-5
references.pmid: 12358576
references.citation: Immunity. 2006 Aug;25(2):271-83
references.pmid: 16872848
references.citation: J Infect Dis. 2008 Jun 1;197(11):1585-93
references.pmid: 18433328
references.citation: Nature. 1987 Nov 5-11;330(6143):80-2
references.pmid: 3313057
references.citation: Microbes Infect. 2000 Mar;2(3):289-94
references.pmid: 10758405
references.citation: Lancet. 2007 Dec 1;370(9602):1840-6
references.pmid: 18061059
references.citation: Immunity. 2002 Feb;16(2):157-68
references.pmid: 11869678
references.citation: Eur J Immunol. 2005 Sep;35(9):2691-8
references.pmid: 16094691
references.citation: Proc Natl Acad Sci U S A. 1983 Sep;80(18):5699-703
references.pmid: 6225125
references.citation: Nat Rev Immunol. 2005 Aug;5(8):641-54
references.pmid: 16056256
references.citation: J Exp Med. 1982 Oct 1;156(4):1000-9
references.pmid: 7153706
references.citation: Virology. 1983 Aug;129(1):170-87
references.pmid: 6310876
references.citation: J Clin Invest. 1996 Jul 1;98(1):50-61
references.pmid: 8690804
references.citation: J Immunol. 2005 Mar 15;174(6):3668-75
references.pmid: 15749905
references.citation: PLoS One. 2007 Jun 13;2(6):e527
references.pmid: 17565380
references.citation: J Clin Invest. 2007 Nov;117(11):3224-35
references.pmid: 17932565
references.citation: J Immunol. 2006 Aug 1;177(3):1904-12
references.pmid: 16849503
references.citation: Am J Pathol. 2003 Sep;163(3):947-56
references.pmid: 12937135
references.citation: Lancet Infect Dis. 2007 May;7(5):319-27
references.pmid: 17448935
references.citation: Emerg Infect Dis. 2008 May;14(5):852-4
references.pmid: 18439383
references.citation: Aust N Z J Med. 1985 Jun;15(3):336-9
references.pmid: 2998316
references.citation: J Virol. 2007 May;81(10):5132-43
references.pmid: 17314163
references.citation: Nat Rev Immunol. 2003 Jan;3(1):23-35
references.pmid: 12511873
references.citation: J Immunol. 2002 Jul 1;169(1):454-9
references.pmid: 12077276
references.citation: Biochem Biophys Res Commun. 1995 Feb 6;207(1):168-74
references.pmid: 7857261
references.citation: J Immunol. 1999 Jun 15;162(12):7285-93
references.pmid: 10358177
references.citation: J Biochem. 1997 Sep;122(3):595-600
references.pmid: 9348089
references.citation: J Immunol. 2004 Oct 15;173(8):4775-8
references.pmid: 15470016
references.citation: Clin Microbiol Rev. 2001 Oct;14(4):909-32, table of contents
references.pmid: 11585790
references.citation: J Immunol. 2007 Jan 15;178(2):1086-95
references.pmid: 17202372
references.citation: J Immunol. 1999 Feb 15;162(4):2281-90
references.pmid: 9973505
references.citation: Immunity. 2002 Apr;16(4):547-58
references.pmid: 11970878
references.citation: J Clin Invest. 1996 Jan 1;97(1):244-9
references.pmid: 8550842
references.citation: Crit Rev Immunol. 2000;20(3):197-222
references.pmid: 10968371
references.citation: J Immunol. 1985 May;134(5):3307-15
references.pmid: 2984286
references.citation: J Immunol. 1995 Nov 15;155(10):4861-7
references.pmid: 7594489
references.citation: Aust N Z J Med. 1981 Apr;11(2):168-73
references.pmid: 6944041
references.citation: J Exp Med. 1983 Jul 1;158(1):258-63
references.pmid: 6864163
references.citation: Trans R Soc Trop Med Hyg. 1965 Mar;59:186-97
references.pmid: 14297194
references.citation: J Virol. 2006 Jan;80(2):737-49
references.pmid: 16378976
references.citation: Lancet Infect Dis. 2007 May;7(5):306-7
references.pmid: 17448932
references.citation: J Immunol. 2001 Mar 1;166(5):3377-83
references.pmid: 11207294
references.citation: J Virol. 2000 Oct;74(19):9294-9
references.pmid: 10982376
references.citation: J Immunol. 1996 Feb 1;156(3):1235-46
references.pmid: 8558003
references.citation: PLoS Pathog. 2008 Mar 14;4(3):e1000023
references.pmid: 18369473
references.citation: Nat Immunol. 2004 Oct;5(10):981-6
references.pmid: 15454921
references.citation: Proc Natl Acad Sci U S A. 1988 Oct;85(20):7734-8
references.pmid: 2971974
references.citation: Arthritis Rheum. 2000 Feb;43(2):365-9
references.pmid: 10693876
references.citation: Clin Exp Immunol. 1988 Jun;72(3):510-5
references.pmid: 3048809
references.citation: J Infect Dis. 2000 Jan;181(1):27-34
references.pmid: 10608747
references.citation: J Gen Virol. 2007 Sep;88(Pt 9):2363-2377
references.pmid: 17698645
references.citation: J Immunol. 2001 Jan 1;166(1):574-81
references.pmid: 11123339
references.citation: Curr Opin Rheumatol. 2004 Jul;16(4):374-9
references.pmid: 15201600